Key result
Adequately powered randomized clinical trials are urgently needed to establish the long-term safety, efficacy, and cardiovascular outcomes of renal denervation for treatment-resistant hypertension.
Population
Patients with treatment-resistant hypertension
Design
Editorial
Authors
Loading...
Renal denervation should not enter routine practice for resistant hypertension; leaves open its long-term role pending definitive RCTs.
Widespread use of renal denervation for resistant hypertension should be restrained until adequately powered randomized clinical trials establish its long-term efficacy and safety.
Persu et al. (2013) conducted an editorial in treatment-resistant hypertension. Renal denervation was evaluated. Adequately powered randomized clinical trials are urgently needed to establish the long-term safety, efficacy, and cardiovascular outcomes of renal denervation for treatment-resistant hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: